Company Announcements

Stryker’s Footprint and Infinity Total Ankle System will be featured at the American College of Foot and Ankle Surgeons Annual Meeting

PORTAGE, Mich.--(BUSINESS WIRE)--Jan. 31, 2024-- Stryker (NYSE: SYK), a global leader in medical technologies, today announced the launch of Prophecy Footprint, an expansion of the Prophecy Surgical Planning system, offering comprehensive surgical planning across the entire foot. The system will be demonstrated at the American College of Foot and Ankle Surgeons (ACFAS) Annual Meeting, Tampa Bay, Fla., Feb. 1-4 (booth #919).

The launch of Prophecy Footprint also coincides with the tenth anniversary of Stryker’s Infinity Total Ankle System, a low-profile implant indicated for total ankle replacement in patients with end-stage ankle arthritis. Since its launch in 2014, the Infinity Total Ankle System has been featured in multiple studies, with the largest series demonstrating 98.8% survivorship at the two-year mark.¹

"Our total ankle and enabling technology portfolios are an incredible example of Stryker's legacy and its commitment to surgeon-driven innovation and enhanced patient care," said Patrick Fisher, vice president and general manager of Stryker’s Foot & Ankle business. “Celebrating a decade of remarkable success, Infinity continues to reflect our commitment to the highest levels of performance. The latest addition to our enabling technology portfolio, Prophecy Footprint, marks a significant milestone as one of the first surgical planning systems that addresses the complexities of the entire foot.” *

With 70% of patients receiving additional procedures at the time of total ankle arthroplasty², assessing the entire foot is essential for understanding a patient-specific procedural approach. Prophecy Footprint elevates surgical planning by providing comprehensive procedural considerations that address concomitant pathology at the time of total ankle arthroplasty.

“Prophecy Footprint offers surgeons more detailed and comprehensive planning capabilities, especially crucial in complex ankle arthroplasty cases," said Dr. Hodges Davis, medical director for Stryker’s Foot and Ankle business. “It enables a more integrated approach and facilitates a more complete view of the foot around the ankle, enhancing the surgical planning experience for surgeons and, as always, the ultimate goal is better clinical outcomes for our patients.”

Prophecy Surgical Planning system’s history of innovation and success includes:

• Over 60,000 ankle procedures planned globally since 2012³
• Achieving 100% post-op neutral alignment⁴
• Saving an average of 38 minutes in the OR⁵
• Delivering an average of $2,500 in cost savings⁶

Stryker’s Foot & Ankle business will be showcasing Prophecy Footprint at the ACFAS meeting. The event will feature an engaging didactic session titled “Advancements in Surgical Planning for Total Ankle Replacement,” led by Dr. Davis and Randy Clements, DPM, that will explore how Prophecy Footprint provides insights into potential ancillary procedures, contributing to the success of total ankle replacements.⁷

About Stryker

Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually. More information is available at www.stryker.com.

A surgeon must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Stryker does not dispense medical advice and recommends that surgeons be trained in the use of any particular product before using it in surgery.

The information presented is intended to demonstrate the breadth of Stryker’s product offerings. A surgeon must always refer to the package insert, product label and/or instructions for use before using any of Stryker’s products. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your sales representative if you have questions about the availability of products in your area.

Content ID: AP-017191

References

1. Townshend, David, et al. Two to Five-Year Outcomes of Total Ankle Arthroplasty with the Infinity Fixed-Bearing Implant: A Concise Follow-up of a Previous Report. The Journal of Bone and Joint Surgery. Vol. 105, no. 23, 6 Dec. 2023, pp. 1846-1856.
2. Penner, et. al. The Infinity Total Ankle System Early Clinical Results With 2- to 4-Year Follow-up, FAS 2018.
3. Stryker’s 2023 sales data
4. Hsu AR, Davis WH, Cohen BE, Jones CP, Ellington JK, Anderson RB. Radiographic Outcomes of Preoperative CT Scan-Derived Patient-Specific Total Ankle Arthroplasty. Foot Ankle Int. May 4 2015.
5. Hamid KS, Matson AP, Nwachukwu BU, Scott DJ, Mather RC, 3rd, DeOrio JK. Determining the Cost-Savings Threshold and Alignment Accuracy of Patient-Specific Instrumentation in Total Ankle Replacements. Foot Ankle Int. Jan 2017;38(1):49-57.
6. Shippert, R. D. (2005). A Study of Time-Dependent Operating Room Fees and How to save $100 000 by Using Time-Saving Products. The American Journal of Cosmetic Surgery, 22(1), 25–34. Hamid KS, Matson AP, Nwachukwu BU, Scott DJ, Mather RC, 3rd, DeOrio JK. Determining the Cost-Savings Threshold and Alignment Accuracy of Patient-Specific Instrumentation in Total Ankle Replacements. Foot Ankle Int. Jan 2017;38(1):49-57.
7. Anastasio, Albert, et al. Nationally Representative Trends in Incidence of Procedures Done Concomitantly with Primary and Revision Total Ankle From 2012 to 2020, Foot and Ankle Specialist, 2023.

* As of January, 2024

View source version on businesswire.com: https://www.businesswire.com/news/home/20240131382541/en/

Andrea Sampson
President/CEO, Sampson Public Relations Group
asampson@sampsonprgroup.com
562.304.0301

Source: Stryker